Você está na página 1de 23

Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 13 of 35 PageID: 1432

EXHIBIT A

Fully executed Tolling and Standstill Agreement received from PBM

Defendants on December 27, 2018.


Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 14 of 35 PageID: 1433

TOLLING & STANDSTILL AGREEMENT

This Tolling & Standstill Agreement (the "Agreement") is made and entered into

between (i) the named plaintiffs and putative class of plaintiffs in In re Insulin Pricing Litigation,

No. 3: l 7-cv-00699 (collectively, the "Insulin Plaintiffs"); (ii) MSP Recovery Claims, Series

LLC, MAO-MSO Recovery, LLC, MSPA Claims 1, LLC, and MAO-MSO Recovery II, LLC

(collectively, the "MSP Plaintiffs"); and (iii) Express Scripts Holding Company, Express Scripts

Inc., UnitedHealth Group Incorporated, OptumRx, Inc., CVS Health Corp., Caremark Rx, Inc.

and Caremark Rx, L.L.C. (collectively, the "PBMs," and together with the Insulin Plaintiffs and

the MSP Plaintiffs, the "Parties"), by and through their respective undersigned attorneys.

WHEREAS, between February and April 2017, several related putative class actions

were filed in the United States District Court for the District of New Jersey alleging violations of

federal and state law in connection with the pricing of certain insulin drugs, including In re

Insulin Pricing Litigation, No. 3:17-cv-00699 (filed Feb. 2, 2017), Barnett v. Novo Nordisk, Inc.,

et al., No. 3:17-cv-01580 (filed Mar. 8, 2017), Boss v. CVS Health Corp., et al., No. 3:17-cv-

01823 (filed Mar. 17, 2017) and Christensen v. Novo Nordisk, Inc., eta/., No. 3:17-cv-02678

(filed Apr. 20, 2017) (collectively, the "Insulin Actions"), some of which named the PBMs as

defendants; and

WHEREAS, on September 7, 2017, the MSP Plaintiffs filed a putative class action

captioned MSP Recovery Claims, Series, LLC, et al v. CVS Health Corp., et al., No. 5:17-cv-

00862, ("MSP') in the United States District Court for the Western District of Texas, alleging

violations of federal and state law in connection with the pricing of certain insulin drugs; and

WHEREAS, on September 18, 2017, the Court appointed Steve W. Berman of Hagens

Berman Sobol Shapiro LLP and James E. Cecchi of Carella, Byrne, Cecchi, Olstein, Brody &

1
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 15 of 35 PageID: 1434

Agnello, P.C. (together, "Insulin Counsel") as interim counsel for the Insulin Plaintiffs, which

gives them the authority "to act on behalf of [the] putative class before" the class has been

certified (see Fed. R. Civ. Pro. 23(g)(3)); and

WHEREAS, on November 17, 2017, the MSP Plaintiffs and the other parties to that

action jointly filed an agreed motion communicating to the MSP court that the "[MSP] Plaintiffs

have voluntarily agreed to litigate the claims made in this case in the District of New Jersey;"

and

WHEREAS, on November 20, 2017, the MSP court entered an order providing that

"[w]ithin 60 days hereof, [MSP] Plaintiffs will either voluntarily dismiss this action without

prejudice or will file a motion to transfer this action to the District of New Jersey"; and

WHEREAS, Insulin Counsel believes it is in the best interest of the Insulin Plaintiffs to

forebear at this time from prosecuting claims against the PB Ms, and on December 26, 2017, filed

a consolidated amended complaint in the Insulin Actions that does not name the PBMs as

defendants; and

WHEREAS, counsel for the MSP Plaintiffs believes it is in the best interest of the MSP

Plaintiffs to forebear at this time from prosecuting claims against the PBMs named as defendants

in MSP and intends to voluntarily dismiss the complaint filed in MSP and to file a complaint in

the District of New Jersey that does not allege claims on behalf of a putative class and does not

name the PBMs as defendants; and

WHEREAS, Insulin Counsel and MSP Counsel wish to protect the Insulin Plaintiffs and

MSP Plaintiffs against any and all prejudice that may result from a delay in the prosecution of

claims against the PBMs should it later be decided that the assertion of such claims is in the

Insulin Plaintiffs' and MSP Plaintiffs' best interests; and

2
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 16 of 35 PageID: 1435

WHEREAS, Insulin Counsel, on behalf of the Insulin Plaintiffs, and MSP Counsel, on

behalf of the MSP Plaintiffs, are willing to delay prosecution of claims against the PB Ms, and the

PB Ms are willing to agree that the statute of limitations for the Insulin Plaintiffs' and MSP

Plaintiffs' potential claims may be tolled as to the PBMs in the manner described below; and

NOW THEREFORE, in consideration of the promises and mutual covenants and

agreements herein contained, the Parties hereby covenant and agree as follows:

TERMS OF AGREEMENT

1. The following defined terms used in this Agreement have the meanings set forth

below.

a. "Agreement" is defined in the preamble.

b. "Covered Claim" means any and all manner of claims, debts, demands,

controversies, obligations, losses, costs, interest, penalties, fees, expenses, rights, duties,

judgments, sums of money, suits, contracts, agreements, promises, damages, causes of

action and liabilities, of every nature and description in law or equity (including, but not

limited to, any claims for damages, whether compensatory, special, incidental,

consequential, punitive, exemplary or otherwise, injunctive relief, declaratory relief,

recession or recessionary damages, interest, attorneys' fees, expert or consulting fees,

costs,· or expenses), whether fixed or contingent, liquidated or unliquidated, accrued or

unaccrued, matured or un-matured, known or unknown, arising under federal, state, local,

statutory, common, administrative, or foreign law, or any other law, rule, or regulation,

brought against any of the PB Ms that relates in any way to the pricing of insulin.

c. ''Expiration Date" means the earlier of (a) the date that final judgments

are entered in all of the Insulin Actions, or (b) the date thirty days after Insulin Counsel

3
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 17 of 35 PageID: 1436

gives written notice to the PB Ms that, on the basis of facts or circumstances that Insulin

Counsel learned after executing this Agreement, they are of the view that it is in the

Insulin Plaintiffs' best interests to include one or more of the PB Ms as a party-defendant

in the Insulin Actions, provided that the date established under subparagraph (b) may not

be earlier than 180 days after the date on which the court has adjudicated all motions to

dismiss in the Insulin Actions.

d. "Insulin Actions" is defined in the first whereas clause.

e. "Insulin Counsel" is defined in the third whereas clause.

f. "Insulin Plaintiffs" is defined in the preamble and consists of the

following plaintiffs named in the consolidated amended complaint filed on December 26,

2017 (ECF No. 82): Henry Appleby, Andre' Arnold, Frank Barnett, Roseanna Barnett,

Andrew Bauer, Aletha Bentele, Julia Blanchette, Mary Bobo, James Bonser, Terry

Brewster, Donald Chaires, Scott Christensen, Julia D' Arrigo, Patricia Dague, Gay

Deputee, Scott Dercks, Mary Ann Devins, Jane Doe, Donald Douthit, F. Donald Fellow,

Mildred Ford, Sarah Gierer, Dianna Gilmore, Gerald Girard, Mark Goldsmith, Michelle

Gwin, Ruth Hart, Diane Halkyard, Sara Hasselbach, David Hernandez, Ritch Hoard,

Michael Horton, Arthur Janz, Emma Jensen, Edward Johnson, Richard Knauss, Angela

Kritselis, Susan Landis, Adam Levett, Jeffrey Liedl, John Loschen, Robert Lowman,

Sean Mac an Airchinnigh, Jeanne MacNitt, Lawrence Mandel, Susan Marsh, Anne

Olinger, Russell Scott Palmer, Juliana Patton, Marilyn Person, Willie Phillips, Patricia

Quint, Donna Ramsey, Robyn Rushing, Marie Saffran, Bertha Sanders, Mark Schloemer,

Howard Schurr, Larissa Shirley, Tremayne Sirmons, Edward Stanford, Michael Starr,

Bret Stewart, Molly Thompson, Jon Ugland, Hector J. Valdes Jr., Hector J. Valdes Sr.,

4
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 18 of 35 PageID: 1437

Andrew Van Houzen, Alethea Weir, Kim and Jim Wallan, and Karyn Wofford, and the

putative class they seek to represent in In re Insulin Pricing Litigation, No. 3:17-cv-

00699.

g. "MSP' is defined in the second whereas 'clause.

h. "MSP Plaintiffs" is defined in the preamble.

1. "Parties" is defined in the preamble.

J. "PBMs" is defined in the preamble.

k. "Timing Defense" means any defense based in whole or in part upon any

statute of limitations, repose period, laches, or any other failure to institute or commence

litigation or other proceedings within a specified period, before a specified date, or before

the happening of a specified event.

2. The Insulin Plaintiffs will not assert, commence, prosecute, institute, or instigate

any Covered Claim brought on behalf of a putative class, or in any way participate, other than as

required by law, in the commencement or prosecution of any other action or other proceeding

asserting any Covered Claim brought on behalf of a putative class up to and including the

Expiration Date.

3. The MSP Plaintiffs will not assert, commence, prosecute, institute, or instigate

any Covered Claim, or in any way participate, other than as required by law, in the

commencement or prosecution of any action or other proceeding asserting any Covered Claim up

to and including the Expiration Date.

4. The time that has been running under any applicable Timing Defense in

connection with any Covered Claim is hereby tolled from and including December 26, 2017, up

to and including the Expiration Date. thus, any Covered Claim will be preserved until the

5
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 19 of 35 PageID: 1438

Expiration Date, unless any Timing Defense already has ripened on such claim before December

26, 2017. If any Insulin Plaintiff or any MSP Plaintiff asserts a,Covered Claim after the

Expiration Date, the time for bringing suit under any applicable Timing Defense will be deemed

to have been tolled during the period beginning with and including December 26, 2017 up to and

including the Expiration Date. Notwithstanding the foregoing, for any Covered Claim that an

MSP Plaintiff might have against UnitedHealth Group Incorporated or OptumRx, Inc., the time

for bringing suit under any applicable Timing Defense will not be deemed to have been tolled for

any period. This Agreement will not operate to revive any period of limitations prescribed by

statute or otherwise for the commencement of any action if such period of limitation already has

run as of December 26, 2017. Provided, however, if any Insulin Plaintiff brings a Covered

Claim on behalf of a putative class before the Expiration Date, the PB Ms will have the right to

terminate the Agreement provided that: (1) they give written notice to Insulin Counsel of the

filing of a Covered Claim; and (2) Insulin Counsel is unable to obtain dismissal of that Covered

Claim within 30 days of notification of the Covered Claim by the PB Ms.

5. This Agreement will not prevent the Parties from seeking discovery under the

Federal Rules of Civil Procedure ("Rules") from the other Parties to this Agreement-,-Qr from

any other party.

6. Except as specifically set forth herein with respect to the tolling of Timing

Defenses, this Agreement will not affect the validity of any of the Parties' respective claims or

defenses. Nothing in this Agreement will be construed as an admission or concession by any

Party regarding the validity or strength of any claim or defense of any other Party; and nothing

herein will alter the Parties' respective legal or evidentiary burdens with respect to any claim or

defense.

6
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 20 of 35 PageID: 1439

7. This Agreement will affect only the Parties hereto and their counsel, and nothing

herein will affect the claims or potential claims, if any, of other persons, entities or non-parties;

nor will it affect any defenses or affirmative defenses to any claim of other persons, entities or

non-parties.

8. Nothing in this Agreement will bar the Parties from bringing any action or claim

to enforce the terms of this Agreement

9. The PB Ms will not use this Agreement as a basis to stay any claims against them

in any case other than the Insulin Actions specifically identified in the first whereas clause

above.

10. This Agreement contains the entire agreement between the Parties and constitutes

the complete, final, and exclusive embodiment of their agreement relating to the subject matter

hereof. The terms of this Agreement are contractual and not a mere recital.

11. The signatories to this Agreement represent that they have the requisite authority

to bind and act on behalf of the respective Parties for whom they sign.

12. This Agreement may not be modified except by a written instrument that

explicitly refers to this Agreement, explicitly purports to modify its terms, and is signed by all

Parties hereto.

13. This Agreement will bind and will inure to the benefit of the Parties.

14. This Agreement will be deemed to have been entered into and will be construed

and enforced in accordance with the laws of the State of New Jersey without regard for New

Jersey's choice-of-law or conflicts-of-laws rules.

15. This Agreement may be executed in two or more counterparts, each of which will

be deemed an original but all of which together will constitute one and the same instrument.

7
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 21 of 35 PageID: 1440

IN WITNESS WHEREOF, the undersigned have duly authorized and caused this

Agreement to be executed.

Dated: January 26, 2018

CARELLA, BYRNE, CECCHI, OLSTEIN, SKADDEN, ARPS, SLATE, MEAGHER &


BRODY & GNELLO, P.C. FLOMLLP

By:-----------
Robert A. Fumerton

Attorney for Defendants Express Scripts


Holding Company and Express Scripts Inc.

HAGENS BERMAN SOBOL SHAPIRO LLP ALSTON & BIRD LLP

By:------------- By: - - - - - - - - - - - - - - - - -
Steve W. Berman Brian D. Boone
Thomas M. Sobol William H. Jordan
Hannah W. Brennan Elizabeth Broadway Brown
Jordan E. Edwards

Attorneys for Defendants UnitedHealth Group


Incorporated and OptumRx, Inc.

8-
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 22 of 35 PageID: 1441

\.

IN' WITNESS WHEREOF, the undersigned have duly .authorized and caused this

Agreement to be executed.

Dated: January 26, 2018

CARELLA, BYRNE, CECCHI, OLST~IN, SKADDEN, ARPS, SLATE, MEAGHER &


BRODY & AGNELLO, P.C. FLOMLLP

By:------------ By:
James E. Cecchi Robert A. Fumerton
Lindsey H. Taylor Patrick G. Rideout

Attorney for Defendants Express Scripts


Holding Company and Express Scripts Inc.

HAGENSBERMANSOBOLSHAPIROLLP ALSTON & BIRD LLP

By:----------- By:------------
Steve W. Berman Brian D. Boone
Thomas M. Sobol William H. Jordan
Hannah W. Brennan Elizabeth Broadway Brown
Jordan E. Edwards

Attorneys for Defendants UnitedHealth Group


Incorporated and OptumRx, Inc.

8
Case 3:17-cv-01823-BRM-LHG Document
--------~--··---·----------·-·-·--·---·-···-··- 67-1 Filed 01/03/19 Page
..······· ··-·-··----'·--'--·-···-'-·--......______ ...........:_................_........___ ...
,
23 of 35 PageID: 1442

IN WITNESS ·WHEREOF, ~e undersigned have duly authod~d and ca14sed this

Agreement·to be executed.

Dated: January 26, 2018

CARELLA, BYRNE, CECCHI, OLSTEIN, SKADDEN, ARPS, SLATE, MEAGHER &


BRODY & AGNELLO, P.C. FLOM LLP

By: By: ·.,---.....,_-----------


James E. Cecchi Robert A Ftimerton
Lindsey H. Taylor
Attorneyfor.DefendantsExpressScripts
Holding CQ,npanyand£xpress Scr.iptslnc.

HAGENS BERMAN SOBOL SHAPIRO ALSTON&.BIRD•·LLP


LLP

By: - - - - - - - - - - - - - - - -
Brilill It. Boone
.Berman WilliamH. .Jordan
· omas M. Sobol Elizabeth Broadway Brown
Hannah W. Brennan Jordan E. Edwards

Attorneysfor>Defenattiits UnitedHealth Group


Incorporated andOptumRx, Jnc;

8
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 24 of 35 PageID: 1443

IN WITNESS WHEREOF, the undersigned have duly authorized and caused this
Agreement to be executed.

Dated: January 26, 2018

CARELLA, BYRNE, CECCHI, OLSTEIN, SKADOEN, ARPS, SLATI;:, MEAGHER &


BRODY & AGNELLO, P.C. FLOM LLP .

By: By: _ _ _ _ _ ___;.__ _ __


James E. Cecchi Robert A. Fumerton
Lindsey H. Taylor
Attorney for Defendants Express Scripts
Holding Company and Express Scripts Inc.

HAGENS BERMAN SOBOL SHAPIRO ALSTON & BIRD LLP


LLP

By:---~-·-~~---
By:----------- Brian D. Boone
Steve W. Berman WiUiam H. Jordan
Thomas M. Sobol Elizabeth Broadway Brown
Hannah W. Brennan Jordan E. Edwards

Attorneys for Defendants UiJitedHealth Group


Incorporated and OptumRx,: Inc.

--------------------------------------·--····--·--·
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 25 of 35 PageID: 1444

MEHR! & SKALET, PLLC WILLIAMS & CONNOLLY LLP

By: - - - - - - - - - - - - -
Craig L. Briskin B:12P:lBoeOO:
Daniel Dockery

Attorneys for Defendants CVS Health


Corporation, Caremark Rx, Inc. and
Caremark Rx, LLC

NUSSBAUM LAW GROUP, P.C. WEITZ & LUXENBERG

By:----------- By:-----------
Linda P. Nussbaum Ellen Relkin
Bradley J. Demuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos

CRIDEN & LOVE, P.A. BERMAN TABACCO

By:------------ By:------------
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy

9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 26 of 35 PageID: 1445

MEHRI & SKALET, PLLC WILLIAMS & CONNOLLY LLP

By: - - - - - - - - - - - - - - - By:-----------
Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery

Attorneys for Defendants CVS Health


Corporation, Caremark Rx, Inc. and Caremark
Rx, L.LC.

NUSSBAUM LAW GROUP, P.C. WEITZ & LUXENBERG

By: , ~ft,1_ l/,,(--'--_.,


J.. By:-----------
Linda P. Nussbaum EJ len Relkin
lffi lli_g 9emth> Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos

CRIDEN & LOVE, P.A. BERMAN TABACCO

By: _________........_ _ __
By:-----------
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy

:9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 27 of 35 PageID: 1446

MEHR! & SKALET, PLLC WILLIAMS & CONNOLLY LLP

By:----------- By:------------
Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery

Attorneys for Defendants CVS Health


Corporation, Caremark Rx, Inc. and Caremark
Rx, L.L.C.

NUSSBAUM LAW GROUP, P.C.

By: ~--~==-----~
=·····=-·-=-
Linda P. Nussbaum
:IT?Cf/~
Ellen Relkin
Bradley J. Demuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos

CRIDEN & LOVE, P.A. BERMAN TABACCO

By: - - - - - - - - - - - - By: - - - - - - - - - - - -
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy

9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 28 of 35 PageID: 1447

MEHRf & SKALET, PLLC WILLIAMS & CONNOLLY LLP

By: --·--·- ·-·. . ·-------·········-·- By:··-· ... ,.........·....,._-"----


Crdig L. Briskin E'nu Mainigi" .
Paul Boehm
Daniel Dockery

Allorneysfor Defendants CVS Health


Corporation, Caremark Rx, Inc. and
Carema1·k Rx, l.L. C.

NUSSBAUM LAW GROUP, P.C. WEITZ & LUXENBERG

By: _ _ _ . __ e:y. - ...


Linda P. Nussbaum Ellen Relkin
Bradley J. Demuth Paul F. Novak
Diana Gjonaj
Gregory S~matopoulos

BERMAN TABACCO

By: . ··--· ...... --··-----·····-~----·--·-·


Todd A. Seaver
Lindsey C. Grossman Jessica Moy

9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 29 of 35 PageID: 1448

MEHR! & SKALET, PLLC WILLIAMS & CONNOLLY LLP

By: ____________________
By:-----------
. Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery

Attorneysfor Defendants CVS Health


Corporation~ Catemark Rx, Inc. and
Caremark Rx, L;L.C.

NUSSBAUM LAW GROUP, P.C. WEITZ & LUXENBERG

By:----------- By:--------------
Linda P. Nussbaum Ellen Relkin -
Bradley J. Dernuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos

CRIDEN & LOVE,.P.A.

By: - - - - - - - - - - - - - - - - -
Michael E. Criden
Lindsey C. Grossman

9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 30 of 35 PageID: 1449

SHEPHERD FINKELMAN MILLER& RAGO LAW


SHAH, LLP

By:-----------
Michelle· Rago
By: - - - - - - - - - - - - - - -
Jayne A. Goldstein
Natalie Finkelman Bennett

CA.FFERTY·CLOBES MERIWETHER&
SPRENGEL LLP

Roberta . Liebenberg By:-----------


Adam J. Pessin Nyran ·Rose· Rasche
Patrick E. Cafferty

KELLER ROHRBACK L.L.P. WEIL & CHARDON LLC

By: - - - - - - - - - - - - - - - - By:------------
Lynn Lincoln Sarko Stephen- H. Weil
Derek W. Loeser
Gretchen S. Obrist
Attorneysforlnsu/in Plaintiffs
On behalf of Plaintiffs Halkyard, Sanders,
Wal/an, Ramsey, and Hart

lO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 31 of 35 PageID: 1450

SHEPHERD FINKELMAN MILLER & RAGO LAW


SHAH, LLP

By:-----------
By:-----------
Michelle Rago
Jayne A. Goldstein
Natalie Finkelman Bennett

FINE, KAPLAN AND BLACK, R.P.C. CAFFERTY CLOBES MERIWETHER &


SPRENGEI LLP

By:-----------
Roberta D. Lieben,berg By: ---~----_,.._.,_______---a..,_;:_-=-----
Adam J. Pessin Nyran Ro
Patrick E.

KELLER ROHRBACK L.L.P. WEIL & CHARDON LLC

By:------------ By:-----------
Lynn Lincoln Sarka Stephen H. Weil
Derek W. Loeser
Gretchen S. Obrist
Attorneys for Insulin Plaintiffs
On behalfofPlaintiffe Halkyatd, Sanders,
Wallan, Ramsey, and Hart

IO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 32 of 35 PageID: 1451

SHEPHERD FINKELMAN MILLER & RAGO LAW


SHAH, LLP

By: - - - - - - - - - - - - - - - -
By:-----------
Michelle Rago
Jayne A. Goldstein
Natalie Finkelman Bennett

FINE, KAPLAN AND BLACK, R.P.C. CAFFERTY CLOBES MERIWETHER & ·


SPRENGEL LLP

By:------------
Roberta D. Litrbenberg ·By:------------
Adam J. Pessin Nyran Rose Rasche
Patrick E. Cafferty

KELLER ROHRBACK L.L.P. WEIL & CHARDON LLC

By:~1nmt~
Lynn Lincoln Sarko
By:------------
Stephen H. Weil
Derek W. Loeser
Gretchen S. Obrist

On behalf ofPlaintiffs Halkyard, Sanders,


Wallan, Ramrey, and Hart

10
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 33 of 35 PageID: 1452

SH£PHERD FINKELMAN MILLER & RAGO LAV./


SHAH. LLP

By:------------
Michelle Rauo
.e
By:--------------
Jayne A. Goldstein
Natalie Finkelman Rennell

FlNE, KAPL~N AND BLACK R.P.C. CAFFERTY CLOBF.S MERIWETHER &


SPRENGEL LLP

By:~~-~~=~~-............-------
Roberta D. Liebcnbcrg By:-------~---
Adum J. Pc~sin Nyran Rose Rasche
Patrick E. Cafferty

KELLER ROHRBACK L.L.P. WEIL & CHARDON LLC

By: - - - - - - - - - ' - - - - - - - , - - -
Lynn Lincoln Sarko
By: ~,i;
St.ire: Weil
1L
Derck W. Loeser
Orcklrnn S. Obri8t
Altonwt·.,ji)r Insulin Plaint!ff.,·
On hcdw(f"~/Plaimil,h.- lla/1'yard. Smulers.
l·Va/lm,; Rmusr.:r. a11d Hatt

JO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 34 of 35 PageID: 1453

CRITCHLEY, KINUM & DENOIA, LLC SERNA & ASSOClA TES PLLC

By: _ _ _____;;._,;.._;,,;___.,;;._________-'----_
By·----"--------------+--------
Michael Critchley~. Enrique G. Serna
Daniel E. Serna
On behalf ofPlaintiffs Halkyard, Sanders,
Wollan, Ramsey, and Hart Attorneys.for MSP Plaintiffs

11
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 35 of 35 PageID: 1454

CRITCHLEY, KINUM & DENOIA, LLC

By:-----------
Michael Critchley

On behalfofPlaintiffs Halkyard, Sanders,


Wal/an, Ramsey, and Hart

11